-
1
-
2
Pharmaceutical R & D spending and threats of price regulation.
Argitaratua izan da Journal of financial and quantitative analysisArtikulua -
3
-
4
-
5
CEO overconfidence and long-term performance following R&D increases.
Argitaratua izan da Financial managementArtikulua -
6
-
7
Flow signals how patterns over tiem affect the acceptance of start-up firms.
Argitaratua izan da Journal of marketingArtikulua -
8
-
9
Measuring distress risk The effect of R&D intensity.
Argitaratua izan da Journal of FinanceArtikulua